Risk Scores for Prediction of Coronary Heart Disease: An Update

Endocrinology and Metabolism Clinics of North America

Volumn 38, Issue 1, 2009, Pages 33-44

  Wilson, Peter W F ^a,b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Cholesterol; Coronary heart disease; Epidemiology; Prediction; Risk factors

Indexed keywords

ALGORITHM; CALIBRATION; CARDIOVASCULAR RISK; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; REVIEW;

ALGORITHMS; CORONARY DISEASE; HUMANS; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 59649116649     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2008.11.001     Document Type: Review

References (46)

1. Wilson P.W., D'Agostino R.B., Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation 97 18 (1998) 1837-1847
2. Walker S.H., and Duncan D.B. Estimation of the probability of an event as a function of several independent variables. Biometrika 54 (1967) 167-179
3. Truett J., Cornfield J., and Kannel W.B. A multivariate analysis of risk of coronary heart disease in Framingham. J Chronic Dis 20 (1967) 511-524
4. Lipid Research Clinics Population Studies. Data book. The Prevalence Study 1980(NIH Publ 80-1527). 1st edition vol. 1 (1990), NIH, Bethesda
5. Lipid Research Clinics Program. Manual of Laboratory Operation. 1st edition (1974), NIH, Bethesda
6. Rifkind B.M., and Segal P. Lipid research clinics program reference values for hyperlipidemia and hypolipidemia. JAMA 250 (1983) 1869-1872
7. Warnick G.R., Myers G.L., Cooper G.R., et al. Impact of the third cholesterol report from the adult treatment panel of the National Cholesterol Education Program on the clinical laboratory. Clin Chem 48 1 (2002) 11-17
8. McNamara J.R., Leary E.T., Ceriotti F., et al. Point: status of lipid and lipoprotein standardization. Clin Chem 43 8 Pt 1 (1997) 1306-1310
9. Myers G.L., Cooper G.R., and Sampson E.J. Traditional lipoprotein profile: clinical utility, performance requirement, and standardization. Atherosclerosis 108 Suppl (1994) S157-S169
10. Cooper G.R., Myers G.L., Smith J., et al. Blood lipid measurements: variations and practical utility. JAMA 267 (1992) 1652-1660
11. Cooper G.R., Smith S.J., Myers G.L., et al. Estimating and minimizing effects of biologic sources of variation by relative range when measuring the mean of serum lipids and lipoproteins. Clin Chem 40 (1994) 227-232
12. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28 (1979) 1039-1057
13. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 7 (1997) 1183-1197
14. Assmann G., Cullen P., and Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 105 3 (2002) 310-315
15. Conroy R.M., Pyorala K., Fitzgerald A.P., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24 11 (2003) 987-1003
16. Kannel W.B., Castelli W.P., Gordon T., et al. Serum cholesterol, lipoproteins, and the risk of coronary heart disease: the Framingham Study. Ann Intern Med 74 (1971) 1-12
17. Wilson P.W.F., Castelli W.P., and Kannel W.B. Coronary risk prediction in adults: The Framingham heart study. Am J Cardiol 59 G (1987) 91-94
18. Anderson K.M., Wilson P.W.F., Odell P.M., et al. An updated coronary risk profile. A statement for health professionals. Circulation 83 (1991) 357-363
19. Anderson K.M., Odell P.M., Wilson P.W.F., et al. Cardiovascular disease risk profiles. Am Heart J 121 (1991) 293-298
20. Joint National Committee. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med 153 (1993) 154-183
21. The Expert Panel. National cholesterol education program. Second report. The expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). Circulation 89 3 (1994) 1333-1345
22. National High Blood Pressure Education Program. The 1988 report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med 148 (1988) 1023-1038
23. D'Agostino Sr. R.B., Grundy S., Sullivan L.M., et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286 2 (2001) 180-187
24. Grundy S.M., D'Agostino Sr. R.B., Mosca L., et al. Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood Institute workshop. Circulation 104 4 (2001) 491-496
25. Cox D.R. Regression models and life tables. J R Stat Soc(B) 34 (1972) 187-220
26. Pencina M.J., and D'Agostino R.B. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 23 13 (2004) 2109-2123
27. D'Agostino Sr. R.B., and Nam B.H. Evaluation of the performance of survival analysis models: discrimination and calibration measures. Handbook of Statistics (vol 23): Advances in Survival Analysis (2004), Elsevier, Amsterdam p. 1-26
28. Liu J., Hong Y., D'Agostino Sr. R.B., et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 291 21 (2004) 2591-2599
29. Diamond G.A., Hirsch M., Forrester J.S., et al. Application of information theory to clinical diagnostic testing. The electrocardiographic stress test. Circulation 63 4 (1981) 915-921
30. Wilson P.W., Nam B.H., Pencina M., et al. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham heart study. Arch Intern Med 165 21 (2005) 2473-2478
31. Cook N.R., Buring J.E., and Ridker P.M. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 145 1 (2006) 21-29
32. Pepe M.S., and Thompson M.L. Combining diagnostic test results to increase accuracy. Biostatistics 1 2 (2000) 123-140
33. Pepe M.S., Janes H., Longton G., et al. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 159 9 (2004) 882-890
34. Pencina M.J., D'Agostino Sr. R.B., D'Agostino Jr. R.B., et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27 2 (2008) 157-172
35. Stevens R.J., Kothari V., Adler A.I., et al. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond) 101 6 (2001) 671-679
36. Ferrario M., Chiodini P., Chambless L.E., et al. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE cohort study prediction equation. Int J Epidemiol 34 2 (2005) 413-421
37. D'Agostino Sr. R.B., Vasan R.S., Pencina M.J., et al. General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation 117 6 (2008) 743-753
38. Califf R.M., Armstrong P.W., Carver J.R., et al. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. J Am Coll Cardiol 27 5 (1996) 1007-1019
39. Eagle K.A., Lim M.J., Dabbous O.H., et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month post-discharge death in an international registry. JAMA 291 22 (2004) 2727-2733
40. Lloyd-Jones D.M., Larson M.G., Beiser A., et al. Lifetime risk of developing coronary heart disease. Lancet 353 9147 (1999) 89-92
41. Lloyd-Jones D.M., Leip E.P., Larson M.G., et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 113 (2006) 791-798
42. Mainous III A.G., Koopman R.J., Diaz V.A., et al. A coronary heart disease risk score based on patient-reported information. Am J Cardiol 99 9 (2007) 1236-1241
43. Gaziano T.A., Young C.R., Fitzmaurice G., et al. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet 371 9616 (2008) 923-931
44. Detrano R., Guerci A.D., Carr J.J., et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 358 13 (2008) 1336-1345
45. Humphries S.E., Yiannakouris N., and Talmud P.J. Cardiovascular disease risk prediction using genetic information (gene scores): is it really informative?. Curr Opin Lipidol 19 2 (2008) 128-132
46. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285 19 (2001) 2486-2497